These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 28099316
1. PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION. Chan CK, Crosson JN, Mein CE, Daher N. Retina; 2017 Oct; 37(10):1820-1831. PubMed ID: 28099316 [Abstract] [Full Text] [Related]
7. PNEUMATIC VITREOLYSIS VERSUS PARS PLANA VITRECTOMY IN FOCAL SYMPTOMATIC VITREOMACULAR TRACTION SYNDROME: A Randomized Trial. Kumar V, Sonkar R, Verma S, Azad SV, Chawla R, Venkatesh P, Vohra R, Kumar A. Retina; 2022 Jul 01; 42(7):1277-1283. PubMed ID: 35723920 [Abstract] [Full Text] [Related]
8. A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit). Stalmans P. Graefes Arch Clin Exp Ophthalmol; 2016 Apr 01; 254(4):617-28. PubMed ID: 26899900 [Abstract] [Full Text] [Related]
10. [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy]. Maier M, Abraham S, Frank C, Lohmann CP, Feucht N. Ophthalmologe; 2017 Feb 01; 114(2):148-154. PubMed ID: 27444007 [Abstract] [Full Text] [Related]
12. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography. Odrobina D, Michalewska Z, Michalewski J, Dzięgielewski K, Nawrocki J. Retina; 2011 Feb 01; 31(2):324-31. PubMed ID: 21416651 [Abstract] [Full Text] [Related]
13. ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group. Wu L, Zas M, Berrocal MH, Arevalo JF, Figueroa M, Rodriguez F, Serrano M, Graue F, Alezzandrini A, Gallego-Pinazo R, Roca JA, Iglicki M, Dalma-Weishauz J, Kozak I, Collado A, Badal J, Maia M, Salcedo-Villanueva G, Quiroz-Mercado H, Fromow-Guerra J, Lozano-Rechy D, Avila M, Chhablani J. Retina; 2016 Oct 01; 36(10):1913-8. PubMed ID: 26966868 [Abstract] [Full Text] [Related]
15. Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis. Thomas AS, Folgar FA, Jaffe GJ, Toth CA, Mahmoud TH. Ophthalmol Retina; 2019 Jan 01; 3(1):42-52. PubMed ID: 30929816 [Abstract] [Full Text] [Related]
16. Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice. Schumann RG, Langer J, Compera D, Luedtke K, Schaumberger MM, Kreutzer T, Mayer WJ, Wolf A, Priglinger SG. Graefes Arch Clin Exp Ophthalmol; 2017 Nov 01; 255(11):2081-2089. PubMed ID: 28755165 [Abstract] [Full Text] [Related]
17. Size and vitreomacular attachment of primary full-thickness macular holes. Philippakis E, Amouyal F, Couturier A, Boulanger-Scemama E, Gaudric A, Tadayoni R. Br J Ophthalmol; 2017 Jul 01; 101(7):951-954. PubMed ID: 27913441 [Abstract] [Full Text] [Related]
19. THE EFFECT OF ELECTIVE CATARACT EXTRACTION BY PHACOEMULSIFICATION IN EYES WITH VITREOMACULAR TRACTION SYNDROME. Mantopoulos D, Prenner JL, Patel VK, Roth DB, Shah SP, Tsavaris O, Fine HF, Wheatley HM. Retina; 2021 Jan 01; 41(1):75-81. PubMed ID: 32106158 [Abstract] [Full Text] [Related]